About Kulira Technologies

About company

Kulira Technologies has launched a proprietary gel technology that will standardize tumor assessment practices in pathology laboratories around the world. Kulira has developed and clinically validated SolidX™, a gel-based Class I medical device that improves tumor preparation, allowing for faster and higher-quality assessment of surgical cancer removal. Kulira is currently expanding it's product portfolio offerings into the additional markets of tissue processing, preservation, and genomic testing.